Oncosis

Calculating rank

USPTO Granted Patents = 5

Forward Citations = 285

Loading Chart...

4 inventors (with patents filed for the assignee):

Bernhard O Palsson (5 out of 50 patents)

Manfred Koller (5 out of 14 patents)

Timothy M Eisfeld (5 out of 14 patents)

4. Elie G Hanania (1 out of 5 patents)

5 patents: Sort by Forward Citations

1. 6804385 - Method and device for selectively targeting cells within a three-dimensional specimen (2004-10-12),

2. 6753161 - Optoinjection methods (2004-06-22),

3. 6642018 - Method for inducing a response in one or more targeted cells (2003-11-04),

4. 6534308 - Method and apparatus for selectively targeting specific cells within a mixed cell population (2003-03-18),

5. 6514722 - Method and apparatus for selectively targeting specific cells within a cell population (2003-02-04),

Company Overview

Oncosis is a biopharmaceutical company focused on developing innovative therapies for cancer. With a strong emphasis on research and development, Oncosis is dedicated to finding novel approaches to treating cancer that target specific pathways and mechanisms of the disease. Through collaborations with leading oncology experts and institutions, Oncosis aims to bring new and effective treatments to patients in need.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

5 Patents

#875 in San Diego, CA

#12,079 in California

#51,669 in US

San Diego, CA, United States of America

Oncosis

Forward Citations = 285

4 inventors:

Bernhard O Palsson (5 out of 50 patents)

Manfred Koller (5 out of 14 patents)

Timothy M Eisfeld (5 out of 14 patents)

4. Elie G Hanania (1 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Oncosis. Retrieved from https://idiyas.com/company/oncosis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]